MedTrace Logo

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

NCT03754231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-31

No results posted yet for this study

Summary

This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system in a paediatric outpatient population in KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Conditions

  • Vital Sign
  • Heart Rate
  • Respiratory Rate

Interventions

OTHER

Heart rate monitoring

The heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing

OTHER

Respiratory rate monitoring

The heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing

Sponsors & Collaborators

  • Renew Group

    collaborator INDUSTRY

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Bao Bei Kelly Low · KK Women's and Children's Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-30
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754231 on ClinicalTrials.gov